Skip to main content
OpenTrials

Clinical trial condition

Breast Carcinoma In Situ

Explore clinical trials studying Breast Carcinoma In Situ. Study availability and eligibility vary by location and protocol.

146 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Breast Carcinoma In Situ trial results

Completed

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

NCT00749931

Conditions
Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations
  • Pacific Breast Care Costa Mesa, California, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars Sinai Hospital Los Angeles, California, United States
  • HOAG Memorial Hospital Newport Beach, California, United States
View all 21 locations
View Trial Details
Completed

MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ

NCT00586326

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
Locations
  • Arizona Oncology Services Phoenix, Arizona, United States
  • Daniel Freeman Hospital Inglewood, California, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars Medical Center Miami Beach, Florida, United States
View Trial Details
Active, Not Recruiting

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

NCT01272037

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Ductal Carcinoma in Situ, +11 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1569 locations
View Trial Details
Active, Not Recruiting

Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS

NCT02926911

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +9 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 141 locations
View Trial Details

Related conditions